Centene’s $340M Volume Ranks 341st as Shares Plunge 2.57% Amid Healthcare Scrutiny

On September 16, 2025, , ranking 341st among U.S. equities. , reflecting a decline in investor sentiment amid broader market volatility.

Analysts attributed the drop to mixed signals from healthcare sector fundamentals, including ongoing regulatory scrutiny over . While Centene’s community-based care strategy remains a long-term growth driver, short-term headwinds from state-level budget adjustments and premium rate negotiations weighed on near-term expectations. Investors also reacted to broader market jitters over interest rate uncertainty, though Centene’s valuation metrics remained anchored to its .

Market participants noted limited catalysts in the near term, with upcoming third-quarter earnings due to provide clarity on enrollment trends and cost controls. Positioning data suggested reduced short-term speculative activity, as large-cap healthcare names faced profit-taking after a summer rally. The stock’s indicated moderate liquidity conditions, with no significant institutional block trades reported during the session.

I can definitely help you evaluate that strategy. Before we proceed, could you please confirm a couple of practical details so I can set up the back-test correctly? 1. Universe definition: Do you want to rank every U.S. listed stock each day, or can we limit the universe (e.g., Russell 3000 or S&P 1500 constituents) to keep the data pull manageable? 2. Position sizing: Should the 500 names be equal-weighted each day (i.e., 0.2% of total capital per stock), or do you prefer another weighting rule (e.g., proportional to dollar volume)? 3. Transaction costs: Would you like to include estimates for commissions/slippage (if so, what rates), or assume frictionless trading? Let me know your preferences and I’ll prepare the data-retrieval plan and run the back-test.